Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-24-132483
Filing Date
2024-12-30
Accepted
2024-12-30 16:02:21
Documents
2

Document Format Files

Seq Description Document Type Size
1 425 tm2430195d5_425.htm 425 27299
2 EXHIBIT 3.1 tm2430195d5_ex3-1.htm EX-3.1 11639
  Complete submission text file 0001104659-24-132483.txt   40761
Mailing Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901
Business Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901 203-406-3700
Cara Therapeutics, Inc. (Filed by) CIK: 0001346830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901
Business Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901 203-406-3700
Cara Therapeutics, Inc. (Subject) CIK: 0001346830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-36279 | Film No.: 241589668
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)